Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| MK-677 (Ibutamoren) | Testosterone Cypionate | |
|---|---|---|
| Category | SARMs | Hormones |
| Standard Dose | Research indicates 10-25 mg daily orally. Clinical trials used 25 mg/day. 10-15 mg may provide GH elevation with fewer side effects. | Research indicates 100-200 mg administered via intramuscular or subcutaneous injection every 7-14 days for testosterone replacement therapy. |
| Timing | Take 30-60 minutes before bedtime. This timing leverages the natural nocturnal GH pulse, maximizes sleep quality benefits, and minimizes daytime appetite increase. Half-life ~24 hours ensures once-daily dosing is sufficient. | Inject on a consistent schedule. Twice-weekly dosing (e.g., Monday/Thursday) reduces peak-trough fluctuations. Morning injection preferred for alignment with circadian testosterone rhythm. |
| Cycle Duration | Can be used continuously for months to years — no cycling required as it works through physiological GH release mechanisms. Clinical trials ran for up to 2 years. Reassess IGF-1 and metabolic markers every 3-6 months. | Ongoing for TRT. If discontinuing, taper and implement PCT protocol. Testicular function suppression occurs within 2-4 weeks of initiation. |
| Evidence Level | moderate_human | strong_human |
MK-677 (ibutamoren) is an orally active, non-peptide growth hormone secretagogue that mimics ghrelin by binding the ghrelin receptor (GHSR1a) in the hypothalamus and pituitary. This triggers pulsatile growth hormone release via the same physiological mechanism as endogenous ghrelin, preserving the natural episodic GH secretion pattern. MK-677 increases GH, IGF-1, and IGFBP-3 levels to those observed in young adults without affecting cortisol levels. It also stimulates appetite through ghrelin receptor activation in the hypothalamus. Unlike exogenous GH injection, MK-677 maintains the pulsatile GH pattern and stimulates all five GH isoforms.
Research indicates 10-25 mg daily orally. Clinical trials used 25 mg/day. 10-15 mg may provide GH elevation with fewer side effects.
Take 30-60 minutes before bedtime. This timing leverages the natural nocturnal GH pulse, maximizes sleep quality benefits, and minimizes daytime appetite increase. Half-life ~24 hours ensures once-daily dosing is sufficient.
Can be used continuously for months to years — no cycling required as it works through physiological GH release mechanisms. Clinical trials ran for up to 2 years. Reassess IGF-1 and metabolic markers every 3-6 months.
Testosterone cypionate is an esterified prodrug of testosterone that undergoes hydrolysis in vivo to release free testosterone. It binds the androgen receptor (AR), activating genomic pathways via AR nuclear translocation and transcription of anabolic genes including IGF-1, satellite cell proliferation, and nitrogen retention. Additionally, testosterone exerts non-genomic effects through membrane-associated AR signaling, modulating calcium influx and MAPK/ERK pathways. Aromatization to estradiol via CYP19A1 (aromatase) maintains bone density and lipid profiles.
Research indicates 100-200 mg administered via intramuscular or subcutaneous injection every 7-14 days for testosterone replacement therapy.
Inject on a consistent schedule. Twice-weekly dosing (e.g., Monday/Thursday) reduces peak-trough fluctuations. Morning injection preferred for alignment with circadian testosterone rhythm.
Ongoing for TRT. If discontinuing, taper and implement PCT protocol. Testicular function suppression occurs within 2-4 weeks of initiation.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →